Selenium Medical

Selenium Medical is a contract manufacturer specializing in tailored solutions for the medical device industry, focusing on surface treatment, injection molding, and sterile packaging, ensuring compliance with stringent industry standards. Founded in 2009 and headquartered in La Rochelle, France, Selenium Medical provides contract manufacturing solutions for the medical device sector. The company has engaged in five deals, with its most recent funding round occurring on September 21, 2018, where it raised EUR 31,360 from an individual investor. The CEO, Damien Uijttewaal, leads the firm as it strives to meet the evolving needs of medical device manufacturers.

Selenium Medical specializes in contract manufacturing solutions specifically designed for the medical device industry. Its core offerings include surface treatment, plastic injection molding in a controlled clean environment, sterile packaging, and consulting services that encompass laboratory testing. The company focuses on creating custom and turnkey solutions that seamlessly integrate into the medical device value chain, addressing the unique needs of manufacturers in sectors such as orthopedics, soft tissues, dental, robotics, and in vitro diagnostics. Among their notable innovations are the SoEasy no-touch holder, SoKlean no-touch dental holder, and SoBliss next-generation blisters, each aimed at enhancing the protection and handling of medical devices.

Selenium Medical serves a diverse client base, including manufacturers and distributors operating primarily in European and North American markets, ensuring that patient well-being is prioritized in every solution they provide. In 2023, Selenium Medical reported a revenue of EUR 11,047,852. 80, with an EBITDA of EUR -401,032. 70.

The company operates on a business-to-business (B2B) model, engaging directly with medical device manufacturers and distributors. Revenue is generated through contracts for customized manufacturing solutions and consulting services that assist clients from development through certification. The company's transactions typically involve upfront agreements for project scopes, followed by phased payments linked to production milestones or delivery schedules. Key products, such as the trademarked SoEasy and SoBliss, are integral to their revenue structure, driving consistent demand within their target markets.

The company's pricing strategy is tailored to the specific requirements of each client, focusing on establishing long-term partnerships that foster innovation and mutual growth. Following its most recent funding round in September 2018, Selenium Medical plans to leverage its EUR 31,360 to enhance its product offerings and expand its market reach. The company is currently designing new products aimed at improving the efficiency of medical device handling and packaging, with anticipated launch dates yet to be announced. Furthermore, Selenium Medical is targeting growth in emerging markets across Asia and South America, with plans to establish a presence in these regions by 2025.